Evidence map›Paper›PMID 28250454›Full record

ArticleNature genetics2017

Mutations in DCC cause isolated agenesis of the corpus callosum with incomplete penetrance.

Ashley P L Marsh, Delphine Heron, Timothy J Edwards, Angélique Quartier, Charles Galea, Caroline Nava, Agnès Rastetter, Marie-Laure Moutard, Vicki Anderson, Pierre Bitoun and 43 more

Open access · greenAbstract read
In one paragraph

Article in Nature genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed
21.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2026
    Article
  4. Review
  5. Corticospinal Tract Development, Evolution, and Skilled Movements.Movement disorders : official journal of the Movement Disorder Society · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Report of a Novel Homozygous IntragenicMolecular syndromology · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

53 authors at 17 institutions in 6 countries.

Ashley P L MarshBruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0001-6049-6931
Delphine HeronAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Timothy J EdwardsQueensland Brain Institute, University of Queensland, St. Lucia, Brisbane, Australia.
Angélique QuartierIGBMC, Université de Strasbourg, CNRS, INSERM, UMR7104 U964, Strasbourg, France.ORCID http://orcid.org/0000-0002-2624-4869
Charles GaleaDrug Delivery, Disposition and Dynamics (D4), Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Caroline NavaAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Agnès RastetterINSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France.
Marie-Laure MoutardAP-HP, Hôpital Trousseau, Service de Neuropédiatrie, Paris, France.
Vicki AndersonDevelopmental Imaging and Child Neuropsychology Research Groups, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Pierre BitounGénétique Médicale, CHU Paris Nord, Hôpital Jean Verdier, Bondy, France.
Jens BuntQueensland Brain Institute, University of Queensland, St. Lucia, Brisbane, Australia.ORCID http://orcid.org/0000-0003-0397-2019
Anne FaudetAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Catherine GarelAP-HP GHUEP, Hôpital Armand Trousseau, Service de Radiologie, Paris, France.
Greta GilliesBruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Ilan GobiusQueensland Brain Institute, University of Queensland, St. Lucia, Brisbane, Australia.
Justine GueganiCONICS Facility, ICM, Paris, France.
Solveig HeideAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Boris KerenAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Fabien LesneAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Vesna LukicBioinformatics Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Simone A MandelstamDepartment of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
George McGillivrayVictorian Clinical Genetics Services, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Alissandra McIlroyDevelopmental Imaging and Child Neuropsychology Research Groups, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Aurélie MéneretINSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France.
Cyril MignotAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Laura R MorcomQueensland Brain Institute, University of Queensland, St. Lucia, Brisbane, Australia.
Sylvie OdentService de Génétique Clinique, Centre de Référence CLAD-Ouest, CHU Rennes, Rennes, France.
Annalisa PaolinoQueensland Brain Institute, University of Queensland, St. Lucia, Brisbane, Australia.
Kate PopeBruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Florence RiantAP-HP, Groupe Hospitalier Saint-Louis -La Riboisière -Fernand Vidal, Laboratoire de Génétique, Paris, France.
Gail A RobinsonNeuropsychology Research Unit, School of Psychology, University of Queensland, Brisbane, Australia.
Megan Spencer-SmithDevelopmental Imaging and Child Neuropsychology Research Groups, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Myriam SrourDepartment of Pediatrics, Montreal Children's Hospital, McGill University, Montreal, Quebec, Canada.
Sarah E M StephensonBruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Rick TankardPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
Oriane TrouillardINSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France.
Quentin WelniarzINSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France.
Amanda WoodDevelopmental Imaging and Child Neuropsychology Research Groups, Murdoch Childrens Research Institute, Parkville, Victoria, Australia.
Alexis BriceAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.
Guy RouleauDepartment of Neurology and Neurosurgery, McGill University Health Center, Montreal, Quebec, Canada.
Tania Attié-BitachINSERM U1163, Laboratory of Embryology and Genetics of Congenital Malformations, Paris-Descartes University, Sorbonne Paris Cité and Imagine Institute, Paris, France.
Martin B DelatyckiBruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Jean-Louis MandelIGBMC, Université de Strasbourg, CNRS, INSERM, UMR7104 U964, Strasbourg, France.
David J AmorBruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.
Emmanuel RozeINSERM, U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle Épinière (ICM), Paris, France.
Amélie PitonIGBMC, Université de Strasbourg, CNRS, INSERM, UMR7104 U964, Strasbourg, France.ORCID http://orcid.org/0000-0003-0408-7468
Melanie BahloPopulation Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0001-5132-0774
Thierry Billette de VillemeurCentre de Référence `Déficiences Intellectuelles de Causes Rares', Paris, France.
Elliott H SherrDepartment of Neurology, UCSF Benioff Children's Hospital, San Francisco, California, USA.
Richard J LeventerDepartment of Paediatrics, University of Melbourne, Parkville, Victoria, Australia.
Linda J RichardsQueensland Brain Institute, University of Queensland, St. Lucia, Brisbane, Australia.
Paul J LockhartBruce Lefroy Centre for Genetic Health Research, Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria, Australia.ORCID http://orcid.org/0000-0003-2531-8413
Christel DepienneAP-HP, Hôpital de la Pitié-Salpêtrière, Département de Génétique, Paris, France.ORCID http://orcid.org/0000-0002-7212-9554
Centre National de la Recherche Scientifique · FRRoyal Children's Hospital · AUSorbonne Université · FRThe University of Queensland · AUMurdoch Children's Research Institute · AUThe University of Melbourne · AUAssistance Publique – Hôpitaux de Paris · FRAston University · GBDélégation Paris 5 · FRHôpital Jean-Verdier · FRInserm · FRMonash University · AUMontreal Children's Hospital · CAMontreal Neurological Institute and Hospital · CAUCSF Benioff Children's Hospital · USVictorian Clinical Genetics Services · AUWalter and Eliza Hall Institute of Medical Research · AU

Funding

De novo copy number variation and gene discovery in human brain malformationsR01NS058721 · NINDS · UNIVERSITY OF CHICAGO · PI ARGILLI, EMANUELA · 2008 to 2025
$10.9M
NINDS NIH HHS R01 NS058721
6 · The paper itself

Abstract

Brain malformations involving the corpus callosum are common in children with developmental disabilities. We identified DCC mutations in four families and five sporadic individuals with isolated agenesis of the corpus callosum (ACC) without intellectual disability. DCC mutations result in variable dominant phenotypes with decreased penetrance, including mirror movements and ACC associated with a favorable developmental prognosis. Possible phenotypic modifiers include the type and location of mutation and the sex of the individual.

Indexed as

Abnormalities, MultipleAgenesis of Corpus CallosumBrainCorpus CallosumDCC ReceptorDevelopmental DisabilitiesFamilyFemaleHumansMaleMutationNervous System MalformationsNeural Stem CellsPenetrancePhenotypeReceptors, Cell SurfaceDCC protein, humanDCC ReceptorReceptors, Cell SurfaceTumor Suppressor Proteins

Identifiers

PMID28250454
PMCPMC5894478
OpenAlexW2591782339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.